November 25, 2014

Mylan on Tuesday confirmed that it — along with several subsidiaries — has been sued by Baxter International, Baxter Healthcare Corp. and Baxter Healthcare S.A. in relation to the filing of an abbreviated new drug application for the generic version of Brevibloc. 

November 24, 2014

Dr. Reddy's Labs on Monday announced the launch of docetaxel injection USP in 20-mg and 80-mg dosage strengths. The drug is the generic version of Taxotere.

 

November 24, 2014

Perrigo on Monday announced that it has agreed to market the authorized generic version of Astellas U.S.' Protopic ointment 0.1% and 0.03%. 

November 21, 2014

A study being published in Annals of Internal Medicine suggests that people with atrial fibrillation who take NSAIDs may be at risk for serious bleeding or thromboembolisms. 

November 20, 2014

Amneal Pharmaceuticals on Thursday announced the launch of Lopreeza (estradiol/norethindrone acetate) tablets in 0.5-mg and 1-mg dosage strengths. The product is the first authorized generic of Activella from Novo Nordisk.

 

November 20, 2014

CVS Health announced on Thursday that the company and its foundation has committed to invest more than $1 million in grants to support tobacco cessation and prevention programs.

November 20, 2014

Dr. Reddy’s Labs announced Thursday that it has launched a bioequivalent generic version of Allegra-D 12 Hour Allergy and Congestion, in the U.S. market.

November 20, 2014

More specialty drug innovation, greater patient access to medicines and reduced impact from patent expiries will be the primary drivers of an increase in global medicine spending of up to 30% by 2018.

November 20, 2014

Matrixx Initiatives on Monday launched Zicam Kids, a cold product specifically designed to provide symptom relief for children ages 6 to 11 years.

November 20, 2014

The Consumer Healthcare Products Association board of directors on Wednesday announced changes to CHPA’s voluntary guidelines addressing dosing of liquid pediatric over-the-counter medicines.

November 20, 2014

Purdue Pharma on Thursday announced that the Food and Drug Administration approved Hysingla ER (hydrocodone bitartrate) extended‐release tablets CII, a once‐daily, single‐entity medication formulated using Purdue’s proprietary extended‐release solid oral platform, Resistec.

November 20, 2014

Rite Aid on Thursday announced Quality Independent Physicians, based in Louisville, Ky., as the latest healthcare provider to join its Rite Aid Health Alliance initiative. 

 

November 19, 2014

Nearly eight in 10 Americans (78%) would consider seeing a healthcare professional virtually for at least one healthcare need, according to a new Harris Poll.

November 19, 2014

The Food and Drug Administration opened a public docket and requested comments on proposed criteria for “first generic” abbreviated new drug application submissions.

 

November 19, 2014

MinuteClinic has opened New Mexico's first retail medical clinics inside three CVS/pharmacy stores in Albuquerque and one in Rio Rancho.

November 19, 2014

Reynolds American on Thursday will be sharing information on the national launch of Zonnic, a smoking cessation gum marketed by the company's subsidiary Niconovum USA.

November 19, 2014

A new national survey shows that while the majority of people (64%) believe sexual health correlates with overall satisfaction in life, more than a quarter shy away from addressing challenges with their doctor. 

November 18, 2014

Chattem on Tuesday announced that IcyHot SmartRelief, a drug-free, over-the-counter pain management system, is now available nationwide.

November 18, 2014

Increasing the amount of omega-3s in your diet, whether from fish or flax, will likely decrease your risk of getting heart disease, according to Penn State nutritionists.

November 18, 2014

Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries, on Tuesday announced that Health Canada has approved its application for PrTeva-Celecoxib, the generic equivalent of PrCelebrex.

November 17, 2014

Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock, the company announced Monday.

November 17, 2014

CRN on Monday submitted comments to the Food and Drug Administration advocating a new qualified health claim for EPA+DHA and blood-pressure reduction. 

November 17, 2014

Four-in-10 U.S. adults are expected to develop Type 2 diabetes at some point in their lifetime, according to a new study published in The Lancet Diabetes & Endocrinology in August, suggesting that as many as 126 million consumers will be looking for treatment options, including self-monitoring their condition at home.

November 17, 2014

Genzyme, a Sanofi company, on Friday announced that the Food and Drug Administration approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis.